These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 13769933)
1. [Disipal and the correction of parkinsonism induced by neuroleptics. (A critical review)]. MEURICE E Acta Neurol Psychiatr Belg; 1961 Jan; 61():47-66. PubMed ID: 13769933 [No Abstract] [Full Text] [Related]
2. [Clinical study on the combined action of orphenadrine and thioproperazine: correction of neuroleptic impregnation and therapeutic synergism]. RUDRAUF J; CHALLOU C Acta Neurol Psychiatr Belg; 1961 Jan; 61():103-9. PubMed ID: 13744502 [No Abstract] [Full Text] [Related]
3. A clinical assessment of orphenadrine (disipal) in the treatment of Parkinsonism. ROBINSON LR; DICK TH Ulster Med J; 1960 Jun; 29(1):64-9. PubMed ID: 14437972 [No Abstract] [Full Text] [Related]
4. [On the medicinal treatment of Parkinson's syndrome. Clinical experiences with disipal]. MUELLER TH Wien Med Wochenschr; 1960 Apr; 110():357-60. PubMed ID: 14424966 [No Abstract] [Full Text] [Related]
5. Assessment of drug therapy in Parkinsonism. ONUAGULUCHI G Br Med J; 1963 Feb; 1(5328):443-8. PubMed ID: 13940177 [No Abstract] [Full Text] [Related]
6. Akineton in the treatment of parkinsonism. O'DOHERTY DS; EDWARDS CE Med Ann Dist Columbia; 1960 Jul; 29():378-80. PubMed ID: 14428055 [No Abstract] [Full Text] [Related]
7. Biperiden (Akineton) in Parkinsonism. TIMBERLAKE WH; SCHWAB RS; ENGLAND AC Arch Neurol; 1961 Nov; 5():560-4. PubMed ID: 13921278 [No Abstract] [Full Text] [Related]
8. Chlorphenoxamine hydrochloride in parkinsonism. A controlled trial. ULDALL PR; WALTON JN; NEWELL DJ Br Med J; 1961 Jun; 1(5240):1649-52. PubMed ID: 13779077 [No Abstract] [Full Text] [Related]
9. Investigations into the so-called reserpine Parkinsonoid in chronic schizophrenics and its treatment with orphenadrine (disipal). van ANDEL Folia Psychiatr Neurol Neurochir Neerl; 1959 Oct; 62():476-88. PubMed ID: 13793294 [No Abstract] [Full Text] [Related]
10. [The psychoanaleptic action of Disipal in the neuroleptic syndrome and in senile depression]. FOUKS L Acta Neurol Psychiatr Belg; 1961 Jan; 61():71-7. PubMed ID: 13701003 [No Abstract] [Full Text] [Related]
11. [Experiences with a new substance for the suppression of Parkinson tremors]. SCHULZ HP Med Klin; 1961 Dec; 56():2174-6. PubMed ID: 13909545 [No Abstract] [Full Text] [Related]
12. [DISIPAL IN THE TREATMENT OF PARKINSON'S DISEASE. A STUDY CONCERNING 80 PATIENTS IN A 6-MONTH PERIOD]. STRANG RR Sven Lakartidn; 1964 Sep; 61():2714-20. PubMed ID: 14227776 [No Abstract] [Full Text] [Related]
13. [CONTRIBUTION TO THE THERAPY AND REHABILITATION OF PARKINSON'S SYNDROME]. GERSTENBRAND F; PATEISKY K Wien Z Nervenheilkd Grenzgeb; 1963 May; 21():124-31. PubMed ID: 14078450 [No Abstract] [Full Text] [Related]
14. A pilot trial of orphenadrine ("disipal") in patients treated with reserpine. LANGLEY GE; ROBIN AA J Ment Sci; 1960 Apr; 106():682-5. PubMed ID: 14413993 [No Abstract] [Full Text] [Related]
15. Psychomotility and parkinsonism in treatment with neuroleptic drugs. FREYHAN FA AMA Arch Neurol Psychiatry; 1957 Nov; 78(5):465-72. PubMed ID: 13468837 [No Abstract] [Full Text] [Related]
16. Treatment of paralysis agitans with orphenadrine (disipal) hydrochloride; results in one hundred seventy-six cases. DOSHAY LJ; CONSTABLE K J Am Med Assoc; 1957 Apr; 163(15):1352-7. PubMed ID: 13415899 [No Abstract] [Full Text] [Related]